在多发性髓瘤细胞上,LILRB4通过p-SHP2/NF-κB/RELT信号通路促进骨损伤

Hongying Wang1, Lei Wang1, Huiwen Luan1

  • 1Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.

概括

白细胞Ig类受体B家族4 (LILRB4) 通过RELT增强骨质细胞分化,促进多发性骨髓瘤骨病变. 阻止LILRB4信号传递会抑制骨损伤,提供治疗点.